Furthermore, a novel high-affinity TrkB agonistic antibody has been shown to suppress necroptosis and apoptosis of neuronal cells, reduce infarct size, and facilitate functional recovery in a rat stroke model [67]. Here, NTRK2 is linked to stroke disorder.